Karo Pharma AB (Karo Pharma AB) EBITDA Margin % : 0.00% (As of Jun. 2022)

Karo Pharma AB EBITDA Margin % Chart

Karo Pharma AB Annual Data
	Trend	Dec12	Dec13	Dec14	Dec15	Dec16	Dec17	Dec18	Dec19	Dec20	Dec21
EBITDA Margin %		Get a 7-Day Free Trial					18.52	40.14	25.78	25.74	25.71

Karo Pharma AB Quarterly Data
	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Jun22
EBITDA Margin %	Get a 7-Day Free Trial															17.98	4.16	13.47	-8.30	-

Competitive Comparison of Karo Pharma AB's EBITDA Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Karo Pharma AB's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Karo Pharma AB's EBITDA Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Karo Pharma AB's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Karo Pharma AB's EBITDA Margin % falls into.

Karo Pharma AB EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Karo Pharma AB's EBITDA Margin % for the fiscal year that ended in Dec. 2021 is calculated as

Karo Pharma AB's EBITDA Margin % for the quarter that ended in Jun. 2022 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Karo Pharma AB  (OTCPK:KARBF) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

Karo Pharma AB EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Karo Pharma AB's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Karo Pharma AB (Karo Pharma AB) Business Description